Skip to main content

Nanotechnology Characterization Lab Staff and Contact Information

The Nanotechnology Characterization Lab (NCL) team has amassed a tremendous knowledge base on the many different types of nanotechnology strategies being used to detect and treat cancer. Learn more about our staff and their expertise below.

Contact the NCL

Nanotechnology Characterization Laboratory
8560 Progress Drive
Frederick, MD 21701

Phone: 301-846-6939
Fax: 301-846-6399
Email: ncl@mail.nih.gov

NCL Staff

  • Marina A. Dobrovolskaia, PhD, MBA, PMP

    Dr. Marina Dobrovolskaia serves as the NCL Director of Operations and manages the Immunology section.

  • Stephan T. Stern, PhD, DABT

    Dr. Stephan Stern serves as the NCL Director of Research & Development and also leads the Pharmacology & Toxicology section as well as the Formulation team.

  • Jeffrey D. Clogston, PhD

    Dr. Jeffrey Clogston is a Principal Scientist at the NCL. He manages the Physicochemical Characterization section.

  • Rachael M. Crist, PhD

    Dr. Rachael Crist is Head of the NCL's Strategic Client Relations. She manages the lab's extramural collaborations, serves as the primary point of contact for collaborators and participates on the NCL's Assay Cascade review committee.

  • Edward Cedrone

    Mr. Edward Cedrone is a Research Associate III in the Immunology Section.

  • Matthew Hansen, PhD

    Dr. Matthew Hansen is a Scientist I within the Physicochemical Characterization section.

  • Ruvanthi Kularatne, PhD

    Dr. Ruvanthi Kularatne is a Scientist II within the Pharmacology & Toxicology section of the NCL, with primary expertise in nanoparticle formulation.

  • Barry Neun, BS

    Mr. Barry Neun is a Research Associate III within the Immunology section.

  • Hannah Newton, PhD

    Dr. Hannah Newton is a post-doctoral fellow within the Immunology section.

  • Timothy Potter, BS

    Mr. Timothy Potter is a Research Associate III within the Immunology section.

  • Amber Pugh

    Ms. Amber Pugh serves as the Administrative Coordinator III for the NCL.

  • Sarah Skoczen, MS

    Ms. Sarah Skoczen is a Research Associate III within the Pharmacology & Toxicology section.

  • Kelsie Snapp, BS, MBA

    Ms. Kelsie Snapp is a Research Associate II within the Pharmacology & Toxicology section.

  • Alison Vermilya, MS

    Ms. Alison Vermilya is a Research Associate I within the Physicochemical Characterization section.

  • Teagan D. Ware, MS, PMP

    Ms. Teagan Ware is a Research Associate III within the Pharmacology & Toxicology section and assists in the design and coordination of animal studies.

  • Jie Xu, MS

    Mr. Jie Xu is a Research Associate I within the Physicochemical Characterization section.